InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 03/22/2019 8:10:37 AM

Friday, March 22, 2019 8:10:37 AM

Post# of 14946
News: $SRNE Sorrento Therapeutics Announces the Merger of Scilex and Semnur to Create a Global Leader in Non-Opioid Pain Management

Semnur’s SP102, addressing multi-billion dollar unmet market needs, in Pivotal Phase 3 Trial with Fast Track Status from the FDA With non-opioid ZTlido, RTX, and SP102 commercial and near-commercial product lines, Sorrento and its subsidiaries are addressing $63 billion market in ...

Got this from https://marketwirenews.com/news-releases/sorrento-therapeutics-announces-the-merger-of-scilex-and-semnur-to-create-a-global-leader-in-non-opioid-pain-management-7863550.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News